首页> 外文OA文献 >HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis
【2h】

HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis

机译:HDL改善胆固醇和葡萄糖稳态,减少了糖尿病相关动脉粥样硬化的动脉粥样硬化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Background and Aims. Apolipoprotein A-I (ApoA-I), the main component of high-density lipoprotein (HDL), not only promotes reverse cholesterol transport (RCT) in atherosclerosis but also increases insulin secretion in pancreatic β-cells, suggesting that interventions which raise HDL levels may be beneficial in diabetes-associated cardiovascular disease (CVD). Previously, we showed that TNF-related apoptosis-inducing ligand (TRAIL) deletion in Apolipoprotein Eknockout (Apoe-/-) mice results in diabetes-accelerated atherosclerosis in response to a “Western” diet. Here, we sought to identify whether reconstituted HDL (rHDL) could improve features of diabetes-associated CVD in Trail-/-Apoe-/- mice. Methods and Results. Trail-/-Apoe-/- and Apoe-/- mice on a “Western” diet for 12 weeks received 3 weekly infusions of either PBS (vehicle) or rHDL (containing ApoA-I (20 mg/kg) and 1-palmitoyl-2-linoleoyl phosphatidylcholine). Administration of rHDL reduced total plasma cholesterol, triglyceride, and glucose levels in Trail-/-Apoe-/- but not in Apoe-/- mice, with no change in weight gain observed. rHDL treatment also improved glucose clearance in response to insulin and glucose tolerance tests. Immunohistological analysis of pancreata revealed increased insulin expression/production and a reduction in macrophage infiltration in mice with TRAIL deletion. Furthermore, atherosclerotic plaque size in Trail-/-Apoe-/- mice was significantly reduced associating with increased expression of the M2 macrophage marker CD206, suggesting HDL's involvement in the polarization of macrophages. rHDL also increased vascular mRNA expression of RCT transporters, ABCA1 and ABCG1, in Trail-/-Apoe-/- but not in Apoe-/- mice. Conclusions. rHDL improves features of diabetes-associated atherosclerosis in mice. These findings support the therapeutic potential of rHDL in the treatment of atherosclerosis and associated diabetic complications. More studies are warranted to understand rHDL’s mechanism of action.
机译:背景和目标。载脂蛋白AI(apoA-i),高密度脂蛋白(HDL)的主要成分,不仅促进动脉粥样硬化中的反向胆固醇转运(RCT),而且增加了胰腺β细胞中的胰岛素分泌,表明培养HDL水平的干预措施有益于糖尿病相关的心血管疾病(CVD)。以前,我们表明,在载脂蛋白Eknockout(ApoE - / - )小鼠中,TNF相关的凋亡诱导配体(TRAP)缺失,导致糖尿病加速动脉粥样硬化,以应对“西方”饮食。在这里,我们寻求识别重构的HDL(RHDL)是否可以改善糖尿病相关的CVD中的特征 - / - ApoE - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - /小鼠中是否可以改善糖尿病相关的CVD的特征。方法和结果。 TRAIL - / - Apoe - / - 和Apoe - / - 饮食中的“西方”饮食12周接受了PBS(车辆)或rhDL的每周输注(含有apoa-i(20 mg / kg)和1-palmitoyl -2-亚油酰磷脂酰胆碱)。 rhDL施用降低血浆胆固醇,甘油三酯和葡萄糖水平,在尾随/ - / - ,但不在atpoe - /小鼠中,观察到重量增量没有变化。 RHDL治疗响应胰岛素和葡萄糖耐量试验还改善了葡萄糖清除。胰腺癌的免疫组织学分析显示出胰岛素表达/生产的增加和巨噬细胞浸润的降低缺失缺失。此外,跟踪/ - apoE - / - 小鼠的动脉粥样硬化斑块尺寸显着降低了与M2巨噬细胞标记CD206的增加表达,表明HDL参与巨噬细胞的极化。 RHDL还增加了RCT转运蛋白,ABCA1和ABCG1的血管mRNA表达,在TRAIL - / - Apoe - / - 但不在ApoE - / - 小鼠中。结论。 RHDL改善了小鼠中糖尿病相关动脉粥样硬化的特征。这些发现支持RHDL治疗动脉粥样硬化和相关糖尿病并发症的治疗潜力。有关更多的研究是为了了解RHDL的行动机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号